Racial and Ethnic Differences in Obesity Treatment in the Veterans Affairs Healthcare System
Tisdale, R. L.; Beyene, T.; Tang, W.; Heidenreich, P.; Asch, S. M.; Yong, C. M.
Show abstract
BackgroundThe burden of obesity in the United States and in the Veterans Affairs (VA) population disproportionately affects minoritized individuals. Major advances in the treatment of obesity have emerged in the last decade, including incretin-based injectables like semaglutide, but it is not clear that they are being distributed equitably. We examined the role that race and ethnicity play in the receipt of a lifestyle change program, medications, and surgical treatment for obesity. MethodsWe analyzed data from patients with BMI [≥]27 in the national VA Healthcare System from 2018-2022. We used multivariate logistic regression to evaluate the association between race/ethnicity (American Indian/Alaska Native [AI/AN], Asian/Native Hawaiian/Pacific Islander [NHOPI], Non- Hispanic Black, Hispanic/Latino, Non-Hispanic White) and use of weight loss interventions (VA lifestyle change program, medication prescriptions, bariatric surgery), adjusting for age, gender, comorbidities, and diagnosis year. ResultsAmong Veterans with BMI [≥]27 (n=2,423,070), 38.8% had Class 1 obesity (BMI 30-34.9), 18.1% had Class 2 obesity (BMI 35-39.9), and 9.8% had Class 3 obesity (BMI>40), with significant differences by race/ethnicity (p<0.01). Across the cohort, 7.7% participated in the lifestyle change program, 7.9% received weight loss medications, and 0.1% underwent bariatric surgery. Compared to Non-Hispanic White patients, Veterans belonging to many racial/ethnic minority groups were more likely to participate in the lifestyle change program (Asian/NHOPI Veterans, 1.12 [95% CI 1.06-1.19]; Non-Hispanic Black Veterans, adj OR 1.24 [95% confidence interval [CI] 1.22-1.26]; Hispanic/Latino Veterans, adj OR 1.17 [95% CI 1.14-1.20]) and less likely to receive weight loss medications (AI/AN Veterans, adj OR 0.84 [95% CI 0.77-0.92]; Asian/NHOPI Veterans: adj OR 0.94 [95% CI 0.89-0.999]; Non-Hispanic Black Veterans, adj OR 0.75 [95% CI 0.74-0.76]; Hispanic/Latino Veterans, adj OR 0.94 [95% CI 0.91-0.97]). Black Veterans were also less likely to undergo bariatric surgery (adj OR 0.79 [95% CI 0.69-0.89]). ConclusionsAmong Veterans with obesity, rates of treatment across all modalities are low. Inequities in treatment approach by race/ethnicity suggest areas for focused intervention to close gaps in care.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom 93%
- Impact of bariatric surgery on monthly earnings and employment: a national linked data study in England, 2014-2022 91%
- Upregulated miR-200c may increase the risk of obese individuals to severe COVID-19 90%
Similar papers in this journal
- Comparative Effects of Weight Loss and Incretin-Based Therapies on Endothelial Vasodilatory and Fibrinolytic Function 92%
- County-level Socio-Environmental Factors and Obesity Prevalence in the United States 92%
- Clinical Characteristics Of Users Of Weight Loss Drugs: Population-Based Case-Control Study 91%
Similar papers in this journal
- Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients 90%
- Covid-19 and Excess Mortality in Medicare Beneficiaries 90%
- Assessing the impact of community-based interventions on hypertension and diabetes management in three Minnesota communities: findings from the prospective evaluation of US HealthRise programs 90%
Similar papers in this journal
- Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: an observational cohort study using the OpenSAFELY platform 93%
- Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans 91%
- Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years 91%
Similar papers in this journal
- Efficacy and safety of phentermine/topiramate in adults with overweight or obesity: A meta-analysis and systematic review 90%
- National, state, and county estimates of adult overweight and obesity from electronic health records and kiosks in retail locations, 2024-2025 90%
- The Pediatric Obesity Microbiome and Metabolism Study (POMMS): Methods, Baseline Data, and Early Insights. 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.